MiR-27a-3p functions as an oncogene in gastric cancer by targeting BTG2

Oncotarget

Volumn 7, Issue 32, 2016, Pages 51943-51954

  Zhou, Lin ^a   Liang, Xin ^b   Zhang, Lingling ^b   Yang, Liyan ^b   Nagao, Norio ^c   Wu, Hongkun ^a   Liu, Chang ^a   Lin, Shengchao ^b   Cai, Guoxiang ^d   Liu, Jianwen ^b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c PREFECTURAL UNIVERSITY OF HIROSHIMA   (Japan)

^d FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

Author keywords

Apoptosis; BTG2; Cell proliferation; Gastric cancer; MiR 27a 3p

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 27A; MICRORNA 27A 3P; MICRORNA 27A 5P; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; RAS PROTEIN; UNCLASSIFIED DRUG; BTG2 PROTEIN, HUMAN; IMMEDIATE EARLY PROTEIN; MIRN27 MICRORNA, HUMAN; TUMOR SUPPRESSOR PROTEIN;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; B CELL TRANSLOCATION GENE 2; CANCER CELL; CANCER GROWTH; CANCER PATIENT; CANCER TISSUE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG TARGETING; G1 PHASE CELL CYCLE CHECKPOINT; GASTRIC CANCER CELL LINE; GENE; GENE ACTIVATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; ONCOGENE; ONCOGENE C MYC; SIGNAL TRANSDUCTION; STOMACH CANCER; STOMACH CARCINOGENESIS; TUMOR GROWTH; UPREGULATION; ANIMAL; BIOSYNTHESIS; GENETICS; NUDE MOUSE; STOMACH TUMOR; XENOGRAFT;

ANIMALS; GENE EXPRESSION REGULATION, NEOPLASTIC; HETEROGRAFTS; HUMANS; IMMEDIATE-EARLY PROTEINS; MICE; MICE, NUDE; MICRORNAS; ONCOGENES; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEINS;

EID: 84982311331     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.10460     Document Type: Article

References (35)

1. Jemal A, Siegel R, Xu J and Ward E. Cancer statistics, 2010 CA Cancer J Clin. 2010; 60:277-300.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D. Global cancer statistics. CA Cancer J Clin. 2011; 61:69-90.
3. Crew KD and Neugut AI. Epidemiology of gastric cancer. World journal of gastroenterology. 2006; 12:354-362.
4. Liu T, Tang H, Lang Y, Liu M and Li X. MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin. Cancer letters. 2009; 273:233-242.
5. Yang Q, Jie Z, Ye S, Li Z, Han Z, Wu J, Yang C and Jiang Y. Genetic variations in miR-27a gene decrease mature miR-27a level and reduce gastric cancer susceptibility. Oncogene. 2012; 33:193-202.
6. Díaz-López A, Moreno-Bueno G and Cano A. Role of microRNA in epithelial to mesenchymal transition and metastasis and clinical perspectives. Cancer Manag Res. 2014; 6:205-216.
7. Ma Y, Yu S, Zhao W, Lu Z and Chen J. miR-27a regulates the growth, colony formation and migration of pancreatic cancer cells by targeting Sprouty2. Cancer letters. 2010; 298:150-158.
8. Mertens-Talcott SU, Chintharlapalli S, Li X and Safe S. The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells. Cancer research. 2007; 67:11001-11011.
9. Guttilla IK and White BA. Coordinate regulation of FOXO1 by miR-27a, miR-96 and miR-182 in breast cancer cells. Journal of Biological Chemistry. 2009; 284:23204-23216.
10. Li Z, Hu S, Wang J, Cai J, Xiao L, Yu L and Wang Z. MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells. Gynecologic oncology. 2010; 119:125-130.
11. Wu XZ, Wang KP, Song HJ, Xia JH, Jiang Y and Wang YL. MiR-27a-3p promotes esophageal cancer cell proliferation via F-box and WD repeat domain-containing 7 (FBXW7) suppression. International journal of clinical and experimental medicine. 2015; 8:15556-15562.
12. Peng H, Wang X, Zhang P, Sun T, Ren X and Xia Z. miR-27a promotes cell proliferation and metastasis in renal cell carcinoma. International journal of clinical and experimental pathology. 2015; 8:2259-2266.
13. Li S, Li J, Fei BY, Shao D, Pan Y, Mo ZH, Sun BZ, Zhang D, Zheng X, Zhang M, Zhang XW and Chen L. MiR-27a promotes hepatocellular carcinoma cell proliferation through suppression of its target gene peroxisome proliferator-activated receptor gamma. Chinese medical journal. 2015; 128:941-947.
14. Xu W, Liu M, Peng X, Zhou P, Zhou J, Xu K, Xu H and Jiang S. miR-24-3p and miR-27a-3p promote cell proliferation in glioma cells via cooperative regulation of MXI1. International journal of oncology. 2013; 42:757-766.
15. Sun Q, Gu H, Zeng Y, Xia Y, Wang Y, Jing Y, Yang L and Wang B. Hsa-mir-27a genetic variant contributes to gastric cancer susceptibility through affecting miR-27a and target gene expression. Cancer science. 2010; 101:2241-2247.
16. Zhao X, Yang L and Hu J. Down-regulation of miR-27a might inhibit proliferation and drug resistance of gastric cancer cells. J Exp Clin Cancer Res. 2011; 30:55.
17. Katada T, Ishiguro H, Kuwabara Y, Kimura M, Mitui A, Mori Y, Ogawa R, Harata K and Fujii Y. microRNA expression profile in undifferentiated gastric cancer. International journal of oncology. 2009; 34:537-542.
18. Matsuda S, Rouault JP, Magaud JP and Berthet C. In search of a function for the TIS21/PC3/BTG1/TOB family. FEBS letters. 2001; 497:67-72.
19. Zhang L, Huang H, Wu K, Wang M and Wu B. Impact of BTG2 expression on proliferation and invasion of gastric cancer cells in vitro. Molecular biology reports. 2010; 37:2579-2586.
20. Zhang YJ, Wei L, Liu M, Li J, Zheng YQ, Gao Y and Li XR. BTG2 inhibits the proliferation, invasion, and apoptosis of MDA-MB-231 triple-negative breast cancer cells. Tumor Biology. 2013; 34:1605-1613.
21. Yang CH, Yue J, Pfeffer SR, Handorf CR and Pfeffer LM. MicroRNA miR-21 regulates the metastatic behavior of B16 melanoma cells. J Biol Chem. 2011; 286:39172-8.
22. Jalava S, Urbanucci A, Latonen L, Waltering K, Sahu B, Jänne O, Seppälä J, Lähdesmäki H, Tammela T and Visakorpi T. Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer. Oncogene. 2012; 31:4460-4471.
23. Liu M, Wu H, Liu T, Li Y, Wang F, Wan H, Li X and Tang H. Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma. Cell research. 2009; 19:828-837.
24. Li Q, Wang G and Zhang Z. The relationship between microRNA-18 and BTG2 in the carcinogenesis of hepatocellular carcinoma. [Article in Chinese]. Zhonghua gan zang bing za zhi. 2009; 17:42-45.
25. Shen K, Liang Q, Xu K, Cui D, Jiang L, Yin P, Lu Y, Li Q and Liu J. MiR-139 inhibits invasion and metastasis of colorectal cancer by targeting the type I insulin-like growth factor receptor. Biochemical pharmacology. 2012; 84:320-330.
26. Xu Y, Xu G, Liu L, Xu D and Liu J. Anti-invasion effect of rosmarinic acid via the extracellular signal-regulated kinase and oxidation-reduction pathway in Ls174-T cells. Journal of cellular biochemistry. 2010; 111:370-379.
27. Ma L, Mao R, Shen K, Zheng Y, Li Y, Liu J and Ni L. Atractylenolide I-mediated Notch Pathway Inhibition Attenuates Gastric Cancer Stem Cell Traits. Biochemical and Biophysical Research Communications. 2014; 450:353-9.
28. Li Y, Shao J, Shen K, Xu Y, Liu J and Qian X. E2F1-dependent pathways are involved in amonafide analogue 7-d-induced DNA damage, G2/M arrest, and apoptosis in p53-deficient K562 cells. J Cell Biochem. 2012; 113:3165-3177.
29. Hatley ME, Patrick DM, Garcia MR, Richardson JA, Bassel-Duby R, Van Rooij E and Olson EN. Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21. Cancer Cell. 2010; 18:282-293.
30. Marampon F, Ciccarelli C and Zani BM. Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors. Molecular cancer. 2006; 5:31.
31. Shen K, Mao R, Ma L, Li Y, Qiu Y, Cui D, Le V, Yin P, Ni L and Liu J. Post-transcriptional regulation of the tumor suppressor miR-139-5p and a network of miR-139-5pmediated mRNA interactions in colorectal cancer. FEBS Journal. 2014; 281:3609-3624.
32. Kawakubo H, Carey JL, Brachtel E, Gupta V, Green JE, Walden PD, and Maheswaran S. Expression of the NF-kappaB-responsive gene BTG2 is aberrantly regulated in breast cancer. Oncogene. 2004; 23:8310-9.
33. Li WQ, Yu HY, Zhong NZ, Hou LJ, Li YM, He J, Liu HM, Xia CY and Lu YC. miR 27a suppresses the clonogenic growth and migration of human glioblastoma multiforme cells by targetingBTG2. Int J Oncol. 2015; 46:1601-8.
34. Sethupathy P, Megraw M and Hatzigeorgiou AG. A guide through present computational approaches for the identification of mammalian microRNA targets. Nat Methods. 2006; 3:881-886.
35. Pintus G, Tadolini B, Posadino AM, Sanna B, Debidda M, Bennardini F, Sava G and Ventura C. Inhibition of the MEK/ERK signaling pathway by the novel antimetastatic agent NAMI-A down regulates c-myc gene expression and endothelial cell proliferation. European Journal of Biochemistry. 2002; 269:5861-5870.